NCT04516005

Brief Summary

Hypertension (HT) has been known for its prominent risk of cardiovascular events. Although there are various pharmacological choices, many patients fail to adhere with them. Therefore, adjunctive non-pharmacological treatment is a promising approach. Foot Reflexology is one of a complementary therapies that has been proved for its ability to decrease blood pressure (BP), however, there is limited data in patients with stage-2 HT. We aimed to examine the effectiveness of foot reflexology as adjunctive therapy for BP lowering. This was a single-center randomized clinical trial. Hypertensive patients who were regularly followed up at the hypertension clinic were enrolled and randomized into the intervention group (n=47) and control group (n=47). Foot reflexology was performed in the intervention group during a clinical visit. Office BP and pulse rate (PR) were measured before and immediately at 15 minutes (min) and 30 min after the procedure in the intervention group and after resting in the control group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2016

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

August 10, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 17, 2020

Completed
Last Updated

August 17, 2020

Status Verified

August 1, 2020

Enrollment Period

7 months

First QC Date

August 10, 2020

Last Update Submit

August 13, 2020

Conditions

Keywords

hypertensionreflexologyacupressuretraditional medicine

Outcome Measures

Primary Outcomes (4)

  • Change of blood pressure level

    The office blood pressures (BP) were measured by a nurse at baseline and at 15 and 30 min after foot reflexology was done in the intervention group. While in the control group, office BPs were measured at baseline and after resting in a quiet room for 15 and 30 min. A validated, FDA-approved automatic BP device (DINAMAP Pro 300, GE healthcare) with the appropriate cuff size for individual arm circumference was used for measurement. Two BP measurements were taken at 2-min intervals, and the average BP were recorded for analyses.

    Change from Baseline Systolic Blood Pressure at 15 minutes

  • Change of blood pressure level

    The office blood pressures (BP) were measured by a nurse at baseline and at 15 and 30 min after foot reflexology was done in the intervention group. While in the control group, office BPs were measured at baseline and after resting in a quiet room for 15 and 30 min. A validated, FDA-approved automatic BP device (DINAMAP Pro 300, GE healthcare) with the appropriate cuff size for individual arm circumference was used for measurement. Two BP measurements were taken at 2-min intervals, and the average BP were recorded for analyses.

    Change from Baseline Systolic Blood Pressure at 30 minutes

  • Change of pulse rate

    The office pulse rate (PR) was measured by a nurse at baseline and at 15 and 30 min after foot reflexology was done in the intervention group. While in the control group, office PR was measured at baseline and after resting in a quiet room for 15 and 30 min.

    Change from baseline pulse rate at 15 minutes

  • Change of pulse rate

    The office pulse rate (PR) was measured by a nurse at baseline and at 15 and 30 min after foot reflexology was done in the intervention group. While in the control group, office PR was measured at baseline and after resting in a quiet room for 15 and 30 min.

    Change from baseline pulse rate at 30 minutes

Secondary Outcomes (2)

  • Difference in degree of reduction of blood pressure between groups

    Difference in degree of reduction of blood pressure from baseline after 30 min

  • Difference in degree of reduction of pulse rate between groups

    Difference in degree of reduction of pulse rate from baseline after 30 min

Study Arms (2)

foot reflexology

EXPERIMENTAL

Foot reflexology was performed in every participant in the foot reflexology group after resting for 5 minutes in a sitting position by the same researcher who was trained and certified by the Department of Thai Traditional and Alternative Medicine, Ministry of Health.

Procedure: foot reflexology

control

NO INTERVENTION

The control group received conventional treatment including anti-HT medications according to the standard HT guideline's recommendations. In the end of the follow-up visit, every participants were informed to adhere to their medication and were encouraged to have healthy lifestyles including salt restriction, regular exercise, and consuming healthy diets.

Interventions

Acupressure was applied at the plantar side of the right foot at the first metatarsal bone, around 1-1.5 centimeters proximal to the first metatarsophalangeal joint. (Figure 2) Approximately 3-kilogram pressure was applied by using a knuckle of the right index finger (dorsal part of the proximal interphalangeal joint in flexing position) in a perpendicular manner and held for 15 seconds (sec) then released for 5 sec. This hold-release cycle was done 5 times over the course of 2 min. This method was recommended by the Department of Thai Traditional and Alternative Medicine in accordance with the Zone theory and the Meridian theory.

foot reflexology

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed stage-2 HT (defined by office SBP≥140 mmHg and/or DBP ≥90 mmHg at first hospital visit)
  • On stable anti-HT drugs for at least 3 months before enrollment.

You may not qualify if:

  • Pregnant women
  • History of foot surgery or bone fracture
  • Skin disease of the foot
  • Diabetes neuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The statistical analysis investigator was blinded to the randomization group
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: a single-center randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

August 10, 2020

First Posted

August 17, 2020

Study Start

November 1, 2015

Primary Completion

May 31, 2016

Study Completion

October 31, 2016

Last Updated

August 17, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will share

Personal contact for IPD

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Until 31st December 2020